BPC Collaborator Event - CBIZ MHM & CLSA Present: Navigating Cyber Security Risks in Life Sciences

CBIZ MHM & CLSA Present: Navigating Cyber Security Risks in Life Sciences

**PLEASE NOTE: We will not accept registrations from individuals or companies offering competitive services to CBIZ and MHM.**

Registration and Networking: 3:30pm
Presentation: 4:00 - 5:30pm
Networking: 5:30 - 6:00pm

Presentation by:
Goran Kovacevic, Director and Cyber Risk Management Services Leader, CBIZ MHM

Together with healthcare, life sciences is becoming one of the most data-intensive industries imaginable, which makes it one of the most susceptible to cyber-risks. However, life sciences companies are still struggling with their capabilities in cyber risk management and have difficulty quantifying the impact of risks and designing effective mitigation plans.
We will help you understand and find answers to these questions:

  • How to identify and determine the effectiveness and value of various information assets on your business
  • How do you determine the level of risk and what is your level of confidence about mitigating controls
  • What impact would a catastrophic security breach have?
  • How do you know when you have achieved an adequate level of security?
  • Are you protecting the sensitive and critical information assets cost-effectively?
  • Are you spending too much or not enough on security?

For more information regarding a refund, complaint, and cancellation policies, contact Kandace Van Tilburg at 858.795.2085 or kandace.vantilburg@cbiz.com

BPC Collaborator Event - CBIZ MHM & CLSA Present: R&D and Other Credits

CBIZ MHM & CLSA Present: R&D and Other Credits

**PLEASE NOTE: We will not accept registrations from individuals or companies offering competitive services to CBIZ and MHM.**

Registration and Networking: 11:30am
Presentation: 12:00 - 1:30pm
Networking: 1:30 - 2:00pm

Presentation by:
Raj Rajan, Managing Director, National Technical Lead - R&D Tax Credits, CBIZ MHM

Research and Development Tax Credits for Start-up, Early Stage and Private and Public Companies
The research and development tax credit is a key government cash incentive meant to keep jobs in the US. Recent legislation has made the credit permanent and further enhanced it to benefit more companies than ever before. However, it is extremely misunderstood area for business owners and CPAs and is a missed opportunity for a significant number of companies in a variety of industries.
You should attend if:

  • You spent significant dollars in developing or improving products or processes or machinery in order remain competitive or an industry leader
  • You come up with new applications or delivery methods for already existing drugs
  • Employees at your companies wear many hats including assisting those in the development department
  • You capture development cost but are uncertain you are maximizing your claim
  • You have or share rights for any patents, trade secrets or intellectual property for new products, processes or technologies
  • You employ engineers, chemists or programmers
  • You looked at the R&D credit in the past and determined that you were facing limitations on using the credits
  • You have less than five years of gross revenue and are trying to develop something to take to market
  • You made any of changes to your production processes related to cost efficiencies, including: new ingredients, formulations, materials, automation, reduced energy consumption, new ways to manufacture or assemble a business component

For more information regarding a refund, complaint, and cancellation policies, contact Kandace Van Tilburg at 858.795.2085 or kandace.vantilburg@cbiz.com

BPC Collaborator Event - BioPharmaPM 2017 Annual Conference

Stepping Up and Stepping Out

Showcasing case studies, skills, and techniques to elevate PM competency, leadership and flexibility in project-based biopharma organizations


Please join us for the 2017 BioPharmaPM Network Conference! We are planning an exciting program for you. Below are a few of our featured speakers, panelists, and trainers who will speak on diverse topics such as managing your career in alignment with your values, leadership development in project management, and how you can solve problems inhibiting project success easily and effectively.

  • William Schiemann, Founder and CEO of Metrus Group and Author
  • Jean Lee, Ph.D., Vice President, Portfolio and Project Management at Pfizer Global Product Development
  • Michael Young, Chief Learning Officer and SVP of Education at the The Medicines Company
  • Mark Velligan, Senior Director of Portfolio Management and Operations at Genentech
  • Trevi Wormley, Managing Director and Chief Solution Engineer at TJ Strategy Group, LLC

We hope you will join us at the San Mateo Marriot in San Francisco May 22-24 and be a part of the only non-profit organization solely committed to project management best practices, development, and networking for biopharma project and program managers.

May 22

  • 5:00-7:00PM: Registration and Opening Networking Reception

May 23

  • 7:30-9:00AM: Registration and Breakfast Networking
  • 9:00AM-5:00PM: Conference Presentations, Panels, Workshops
  • 5:00-7:00PM: Evening Networking Reception

May 24

  • 7:30-9:00AM: Breakfast Networking
  • 9:00AM-2:30PM: Conference Presentation, Panels, Workshops
  • 2:30PM: Conference Conclusion



Early Bird Registration (through March 31): $695 (plus payment processing fees)

Regular Conference Registration (after March 31): $895 (plus payment processing fees)

All registrants will receive a complimentary one-year BioPharmaPM Network membership (a $50 value).


How can I contact the organizer with any questions?
For questions, please contact Kelly Magnuson at kmagnuson@biopharmapm.org

How do I make room reservations?
We are holding a few rooms at a discounted rate with the San Mateo Marriott. If you require a room, please email Kelly Magnuson at kmagnuson@biopharmapm.org for details.

BPC Partner Event - EBBN Fall Mixer

East Bay Bio Network Fall Mixer

East Bay Bio Network (EBBN) is putting together fall networking event.

6pm – Arrival and Check-in

6pm – 7pm – Have a drink and mingle

7-7:15pm – Announcements and Free Raffle

7:30pm – 9pm – More drinks and networking

Catch the latest biotech research over drinks and expand your network.

Remember, bring a bottle of wine or craft beer for the free raffle to make an announcement…any kind of announcement. Bring your business card for drawing.

Click Here for More Information

Contact: Neeraj Sharma
Contact Phone: 706-254-4322
Contact Email: nsharma.cell@gmail.com

Aloft Hotel
8200 Gateway Blv, Newark, CA

BPC Partner Event - BDC Sep 30, 2015

Biotech Vendor Services

SF Biotech Community Event

We are very excited to announce a special Biotech Community Event in SSF on September 30th!!

We are inviting local life science researchers & entrepreneurs in South San Francisco & around the Bay to attend.

When:      Wednesday, September 30, 2015, 5:00-8:00 PM

Where:     Dominic's at Oyster Point
                  360 Oyster Point Blvd
                  South San Francisco, CA, 94080

Pricing:    Free

Register:   www.bvsweb.com

This will be a wonderful way for fellow scientists and entrepreneurs to connect and network, and visit with the best suppliers in the industry!

Featuring guest speaker: Josh Molho from Zephyrus Biosciences

Life science companies attend for FREE and service providers will pay $50.00.

BPC Partner Event - BDC Nov 12, 2015

Seminar: “Bridging the Continents – European Regulatory Affairs & Business Development”

Asphalion & Mitelos hereby invite you to attend the first seminar and wine networking event “Bridging the Continents – European Regulatory Affairs & Business Development.  

The EU can come with difficulties for success. With more than 20 years of experience in the European regulatory environment, our speakers will present the important steps for setting the strategy for successful European submissions.

When:      Thursday, November 12, 2015; 11am-5pm

Where:     Embassy Suites, 150 Anza Blvd.
                 Burlingame CA
                 San Francisco Airport Waterfront

Pricing:    $60 Early Bird RSVP by Nov. 1st
                $75.00 RSVP after Nov. 1st or at the door

Register:   https://www.eventbrite.com/e/bridging-the-continents-european-regulatory-affairs-business-development-tickets-18677145846


  • Lidia Cánovas (ASPHALION) MBA, Pharmacy
    o   20+ years overall experience in pharmaceutical industry
    o   Regulatory Affairs Director and Vice-Director for Research and Development in the Pharmaceutical Industry
    o   10 years as GM and Director of Regulatory Affairs in Asphalion.
  • Remco Munnik (ASPHALION):
    Regulatory Information Director in Asphalion
    o   10+ years industry experience focusing on submission procedures, responsible for electronic submission projects and xEVMPD.
    o   Chairman of an Industry working group for Telematics/eSubmission and EGA member.
  • Joaquim Colomé (MITELOS) M.D., Post-Graduate Degree on Pharmaceutical Medicine & MBA:
    o   25+ years of pharmaceutical industry experience in Europe as a Medical Advisor & Head of Business Development.
    o   CEO & Founder of Mitelos Bioscience
  • Bruce E. Thompson (REGULIANCE) MBA, University of Guelph
    o   U.S. Agent with 20+ years in the pharmaceutical/biotech industries with skills in product development planning, regulatory strategy and project management.
    o   CEO & Founder of Reguliance, a consultancy company focused on US FDA-related pharmaceutical and biopharmaceutical development and commercialization. 

Who Should Come? CEOs, CSOs, COOs, CFOs, Regulatory, Preclinical, Clinical, & CMC Development, Quality & Business Development professionals

Following the Q&A portion of the event will be a wine and hor d’ourve reception, to learn more about our European partners and network with leaders in the industry. Thank you for your support and we look forward to seeing you there!

About the Topics:

  • European Union Regulatory Framework
    o   Who is Who In European Regulatory for Pharmaceuticals and Biologics?: EMA, HMA, NCAs
    o   European Procedures to obtain Marketing Authorization Application – Centralized, Decentralized, Mutual Recognition Procedure and National. Timelines and Requirements
    o   Cost of Regulatory Activities
  • Regulatory Interactions with European Authorities to Approval
    o   Orphan Drug Designation Clinical Trial Applications and IMPDs
    o   Scientific Advice (EMA and NCA)
    o   Bridging US development programs to Europe / parallel development
    o   Pre-submission meetings
  • Business Development in Europe
    o   Political & economic scenario
    o   Pharmaceutical market: characteristics & drivers
    o   Pricing and Reimbursement in Europe
    o   What are European companies looking for?

About the sponsors:

·         ASPHALION, an International Regulatory & Scientific Consultancy firm based in Barcelona and Munich, offers comprehensive services for Drug Development and Regulatory Affairs to Pharma, Biotech and Medical Devices companies. The 60 person team has experts in various areas related to pre-clinical, clinical, CMC/quality, pharmacovigilance, national and international procedures, e-submissions and more.

·         MITELOS, an independent, privately-owned pharmaceutical company, devoted to two main activities: proprietary products development and consultancy for third party companies in the areas of project management and business development.